Search results for "Multicenter"

showing 10 items of 378 documents

Use of a new cross-linked collagen membrane for the treatment of dehiscence-type defects at titanium implants: a prospective, randomized-controlled d…

2009

OBJECTIVES The aim of the present randomized-controlled double-blinded clinical multicenter study was to assess the use of either a new cross-linked (VN) or a native collagen membrane (BG) for the treatment of dehiscence-type defects at titanium implants. MATERIAL AND METHODS A total of n=54 patients were recruited in four German university clinics. According to a parallel-groups design, dehiscence-type defects at titanium implants were filled with a natural bone mineral and randomly assigned to either VN or BG. Submerged sites were allowed to heal for 4 months. Primary (e.g., changes in defect length - DeltaDL, quality of newly formed tissue [0-4] - TQ) and secondary parameters (e.g., memb…

AdultMalemedicine.medical_specialtyBone RegenerationDouble blindedUrologyAlveolar Bone Losschemistry.chemical_elementBone MatrixBiocompatible MaterialsDehiscencePostoperative ComplicationsDouble-Blind MethodOsseointegrationOsteogenesisSurgical Wound DehiscencemedicineHumansProspective StudiesBone regenerationDental ImplantsTitaniumMineralsWound Healingbusiness.industryCollagen membraneSoft tissueMembranes ArtificialSurgerychemistryMulticenter studyBone SubstitutesFemaleImplantCollagenOral SurgerybusinessTitaniumDental AlloysFollow-Up StudiesClinical oral implants research
researchProduct

Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial

2007

OBJECTIVE. The purpose of this study was to compare gadobenate dimeglumine–enhanced MR angiography and unenhanced time-of-flight MR angiography for the detection of significant peripheral arterial occlusive disease using digital subtraction angiography as our reference standard. SUBJECTS AND METHODS. Two hundred seventy-two patients underwent MR angiography and digital subtraction angiography of the iliofemoral arteries. MR angiography was performed before (2D time-of-flight acquisitions) and after (spoiled gradient-echo acquisitions) the administration of 0.1 mmol/kg of gadobenate dimeglumine at 1–2 mL/s. Contrast-enhanced MR angiography and digital subtraction angiography of the calf arte…

AdultMalemedicine.medical_specialtyContrast MediaLumen (anatomy)Arterial Occlusive DiseasesArterial Occlusive Diseases/*diagnosis Contrast Media Image Enhancement/*methods Magnetic Resonance Angiography/*methods Meglumine/*analogs & derivatives/therapeutic useSensitivity and SpecificityMegluminecontrast agents; diagnostic performance; gadobenate dimeglumine; MR angiography; peripheral arterial occlusive diseasediagnostic performancePeripheral arterial occlusive diseaseMulticenter trialOrganometallic CompoundsHumansMedicineRadiology Nuclear Medicine and imagingcontrast agentsGADOBENATE DIMEGLUMINEAgedPeripheral Vascular DiseasesMR angiographymedicine.diagnostic_testbusiness.industryVascular diseaseMr angiographyReproducibility of ResultsGeneral MedicineDigital subtraction angiographyMiddle AgedSouth Americacontrast agentImage Enhancementmedicine.diseaseEuropemedicine.anatomical_structureThighFemaleRadiologybusinessperipheral arterial occlusive diseaseMagnetic Resonance AngiographyArterygadobenate dimeglumine
researchProduct

Survival and tissue maintenance of an implant with a sloped configurated shoulder in the posterior mandible-a prospective multicenter study.

2016

Aim Clinical studies evaluating the influence of the implant design on the preservation of peri-implant keratinized mucosa are rare. The aim of this prospective multicenter study was to investigate the survival, and soft and hard tissue maintenance of an implant with a sloped shoulder configuration, when placed in the posterior mandible. Material and Methods In this study, 24 centers participated and 184 patients receiving 238 implants (OsseoSpeed™ Profile TX implants) were included. Clinical assessments of soft tissue parameters were performed before implant placement, immediately after implant placement, at prosthetic delivery and at 6, 12 and 24 months after implant placement and margina…

AdultMalemedicine.medical_specialtyDentistryMandible01 natural sciences010104 statistics & probability03 medical and health sciences0302 clinical medicinemedicineAlveolar ProcessHumansProspective Studies0101 mathematicsProspective cohort studySurvival rateSurvival analysisAgedAged 80 and overDental Implantsbusiness.industryAlveolar processMandibleMouth MucosaSoft tissue030206 dentistryMiddle AgedSurvival AnalysisSurgerymedicine.anatomical_structureMulticenter studyDental Prosthesis DesignTooth ExtractionKeratinsFemaleImplantOral SurgerybusinessClinical oral implants research
researchProduct

NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

2011

The NOA-05 multicenter trial was performed to analyze the efficacy of primary chemotherapy with procarbazine and lomustine (PC) in patients with gliomatosis cerebri (GC) and to define clinical, imaging, and molecular factors influencing outcome.Thirty-five patients with previously untreated GC were treated with up to six 56-day courses of 110mg/m(2) lomustine on day 1 and 60mg/m(2) procarbazine on days 8 to 21. The primary endpoint was the rate of patients without therapy failure (defined as progressive disease, death from any cause, or termination of PC therapy before the end of course 4) at 8 months after the beginning of PC chemotherapy.The failure-free survival rate at 8 months was 50.3…

AdultMalemedicine.medical_specialtyEndpoint DeterminationGliomatosis cerebriAntineoplastic AgentsGene mutationProcarbazineGastroenterologyDisease-Free SurvivalLomustineInternal medicineMulticenter trialAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorMedicineHumansProspective StudiesKarnofsky Performance StatusSurvival rateDNA Modification MethylasesAgedbusiness.industryTumor Suppressor ProteinsHazard ratioBrainLomustineMiddle Agedmedicine.diseasePrognosisCombined Modality TherapyMagnetic Resonance ImagingNeoplasms NeuroepithelialSurvival AnalysisSurgeryDNA Repair EnzymesTreatment OutcomeNeurologyProcarbazineSample SizeDisease ProgressionFemaleNeurology (clinical)businessProgressive diseasemedicine.drugAnnals of neurology
researchProduct

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

2004

We assessed the effectiveness and safety of an induction dose of peginterferon alfa-2b (PEG-IFN) plus ribavirin for initial treatment of patients with genotype 1 chronic HCV infection in a randomized, controlled, multicenter trial.Three hundred and eleven naïve patients infected with genotype 1 and chronic hepatitis were randomly assigned to 48-week treatment with PEG-IFN once weekly (80-100 micrograms depending on body weight for 8 weeks, followed by 50 micrograms for the next 40 weeks), or standard interferon alfa-2b (IFN) 6 million units on alternate days, both in combination with ribavirin (1000-1200 mg/day).PEG-IFN plus ribavirin significantly increased sustained virological response (…

AdultMalemedicine.medical_specialtyGenotypeCombination therapyFibrosiHepacivirusAlpha interferonHepacivirusInterferon alpha-2Antiviral AgentsGastroenterologyPolyethylene Glycolslaw.inventionchemistry.chemical_compoundRandomized controlled triallawMulticenter trialInternal medicineRibavirinmedicineHumansCombination therapyHepatologybiologybusiness.industryRibavirinfibrosisInterferon-alphavirus diseasesDrug ToleranceHepatitis CHepatitis C ChronicMiddle Agedbiology.organism_classificationmedicine.diseaseRecombinant Proteinsdigestive system diseasesMulticenter trial; Combination therapy; fibrosischemistryMulticenter trialImmunologyPeginterferon alfa-2bFemaleSafetybusinessmedicine.drugJournal of Hepatology
researchProduct

"Readiness to Change" Predicts Efficacy of Reduction among Smokers with Severe Mental Illness.

2018

<b><i>Aims:</i></b> Smoking cessation in subjects with a severe mental illness (SMI) is a challenging but attainable goal. Furthermore, the identification of variables involved in the quitting process is a highly relevant factor in clinical practice. This study aimed to analyze the influence of smokers’ motivation in smoking reduction and cessation and select the most suitable way of measuring motivation. <b><i>Methods:</i></b> This is a secondary analysis of a 9-month, multicenter trial examining a Multicomponent Smoking Cessation Program in 82 adult outpatients with SMI. At the end of the preparation stage, the smokers’ motivational level wa…

AdultMalemedicine.medical_specialtyHealth (social science)Bipolar Disordermedia_common.quotation_subjectmedicine.medical_treatmentMedicine (miscellaneous)Multicenter trialStatistical significancemedicineHumansBipolar disorderLongitudinal StudiesSmoking Reductionmedia_commonCarbon MonoxideMotivationSmokersbusiness.industryAbstinenceMiddle AgedMental illnessmedicine.diseasePsychiatry and Mental healthSchizophreniaPhysical therapySchizophreniaSmoking cessationFemaleSmoking CessationbusinessEuropean addiction research
researchProduct

Clinical performance of a new medullary humeral nail: antegrade versus retrograde insertion.

2001

Objective A new intramedullary nail system for humeral shaft fractures is evaluated to determine whether retrograde nailing is as reliable as antegrade nailing. Study design Prospective multicenter nonrandomized clinical study. Patients Eighty-four patients with acute humeral shaft fractures were nailed with the new unreamed humeral nail (UHN) system. Fifty-seven nails were introduced retrogradely, and twenty-seven antegradely. Bone healing and functional outcome were the follow-up parameters. Results The ratio of perioperative complications was equivalent for both groups, but one shaft fracture and three fractures or fissures at the entry point occurred in the group with retrograde nail in…

AdultMalemedicine.medical_specialtyHumeral FracturesMedullary cavityAdolescentBone healingBone Nailslaw.inventionIntramedullary rodlawFracture fixationmedicineHumansMulticenter Studies as TopicOrthopedics and Sports MedicineHumerusProspective Studiesskin and connective tissue diseasesAgedAged 80 and overFracture HealingOsteosynthesisintegumentary systembusiness.industryGeneral MedicineMiddle AgedSurgeryFracture Fixation IntramedullaryRadiographyDiaphysismedicine.anatomical_structureOrthopedic surgerySurgeryFemalebusinessJournal of orthopaedic trauma
researchProduct

Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial.

2011

Objective To evaluate the efficacy and safety of an intraoral electrostimulation device, consisting of stimulating electrodes, an electronic circuit, and a power source, in treating xerostomia. The device delivers electrostimulation through the oral mucosa to the lingual nerve in order to enhance the salivary reflex. Methods The device was tested on a sample of patients with xerostomia due to Sjogren's syndrome and other sicca conditions in a 2-stage prospective, randomized, multicenter trial. Stage I was a double-blind, crossover stage designed to compare the effects of the electrically active device with the sham device, each used for 1 month, and stage II was a 3-month open-label stage d…

AdultMalemedicine.medical_specialtyImmunologySettore MED/50 - Scienze Tecniche Mediche ApplicateElectric Stimulation TherapySeverity of Illness IndexXerostomialaw.inventionRandomized controlled trialQuality of lifestomatognathic systemRheumatologyDouble-Blind MethodlawSettore MED/28 - Malattie OdontostomatologicheMulticenter trialSeverity of illnessotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansPharmacology (medical)Prospective StudiesOral mucosaProspective cohort studyAgedxerostomia; dry mouth; salivary gland hypofunction; saliva; electrical stimulation; electrostimulation; Sjögren’s syndromeIntention-to-treat analysisToxicitybusiness.industryMouth MucosaMiddle AgedDry mouthSurgeryOral cavityIntention to Treat Analysisstomatognathic diseasesmedicine.anatomical_structureSjogren's SyndromeTreatment OutcomeAnesthesiaFemalemedicine.symptombusinessArthritis and rheumatism
researchProduct

Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial.

2007

PURPOSE: The maximum resting pressure in the anal canal is greatly raised after hemorrhoidectomy. This increase is likely to be the cause of postoperative pain, which is still the most troublesome early problem after hemorrhoidectomy. This study was designed to compare, after hemorrhoidectomy, the effects of intrasphincter injection of botulinum toxin vs. application of glyceryl trinitrate ointment in improving wound heating and reducing postoperative pain at rest or during defecation. METHODS: Thirty patients with hemorrhoids of third and fourth degree were included in the study and randomized in two groups. Anorectal manometry was performed preoperatively and 5 and 40 days after hemorrhoi…

AdultMalemedicine.medical_specialtyManometryRestMULTICENTERPLACEBO-CONTROLLED TRIALHemorrhoidslaw.inventionInjectionsOintmentsNITROGLYCERIN OINTMENTNitroglyceringlyceryl trinitrateHemorrhoidsHEADACHERandomized controlled triallawmedicineHumansbotulinum toxinBotulinum Toxins Type AAdverse effectDefecationNEURONSPain MeasurementPain PostoperativeNITRIC-OXIDEhemorrhoidectomy CHRONIC ANAL-FISSUREbusiness.industryAnorectal manometryGastroenterologyGeneral MedicineAnal canalmedicine.diseaseDOUBLE-BLIND TRIALBotulinum toxinColorectal surgerySurgerymedicine.anatomical_structureTreatment OutcomeSPHINCTEROTOMYNeuromuscular AgentsAnesthesiaDefecationFemalebusinessmedicine.drugDiseases of the colon and rectum
researchProduct

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders : Valid predictors of symptomatic response and remiss…

2010

To examine quality of life and subjective well-being as predictors of symptomatic treatment outcome.Biweekly PANSS ratings were performed in 285 inpatients with schizophrenia spectrum disorders within a multicenter trial by the German Research Network on Schizophrenia. Quality of life and subjective well-being were assessed using the Medical Outcomes Study-Short Form 36-Item Health Survey (SF-36), the Subjective Well-being Under Neuroleptic Treatment Scale (SWN-K) and the Adjective Mood Scale (AMS). Response was defined as an initial 20% PANSS total score reduction and remission according to the consensus criteria. Correlation analysis, logistic regression and CART-analysis were performed.I…

AdultMalemedicine.medical_specialtyMedizinLogistic regressionMood scale03 medical and health sciencesYoung Adult0302 clinical medicineQuality of lifeMulticenter trialInternal medicinemedicineHumansSubjective well-beingBiological PsychiatryPsychiatric Status Rating ScalesMiddle Agedmedicine.diseasePrognosisAntidepressive Agents3. Good health030227 psychiatryHospitalizationPsychiatry and Mental healthTranquilizing AgentsPsychotic DisordersSchizophreniaCorrelation analysisQuality of LifeSchizophreniaDrug Therapy CombinationFemaleSchizophrenic PsychologyPsychology030217 neurology & neurosurgerySchizophrenia spectrumClinical psychologyAntipsychotic Agents
researchProduct